Post-earnings recap
Reported
Tue, Oct 25, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio-Techne Corp's earnings report showed a slight miss on EPS, which contributed to a 5.08% decline in stock price. The lack of revenue data and guidance may have added to investor uncertainty. Management's cautious tone suggests they are aware of market challenges but are focused on future growth opportunities.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.81 | N/A | -1.46% |
Management expressed a commitment to driving innovation despite current market challenges. They emphasized a long-term growth strategy.
Management highlighted ongoing investments in innovation.
They acknowledged challenges in the market but remain focused on long-term growth.